Share on

Europe Vascular Closure Devices Market Research Report - Segmented By Type, Access, Procedure, End User and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3398
Pages: 177
Formats: report pdf report excel report power bi report ppt

Europe Vascular Closure Devices Market Size (2022 to 2027)

The Vascular Closure Devices Market in Europe was worth USD 2.86 billion in 2022 and is estimated to be growing at a CAGR of 6.9% to reach USD 4.00 billion by 2027.

Vascular closure devices are used to achieve homeostasis after the puncturing of an artery during catheterization procedures. Puncturing is typically done to the femoral artery to conduct angiogram tests or for endovascular surgeries. The vascular closure devices include a suture or a small piece of collagen, or a metallic clip. VCDs have achieved significant growth since their introduction. Before the introduction of VCDs, manual compression was used to achieve homeostasis. It is a painful procedure, and it requires anticoagulation agents, and it also requires bed rest for patients for long periods. VCDs decreased the time and effort necessary for stopping the blood flow and increased comfort for patients.

The decrease in access site complications due to the usage of VCDs, decreased discharge time, and an increase in cardiovascular devices are the major factors driving the vascular closure devices market. A rise in popularity for minimally invasive surgeries and increased adoption of the latest technology and devices in healthcare is also expected to drive the market.

The most important factors driving the market's growth are the increasing prevalence of cardiovascular diseases, the increase in the number of obese people, the growing number of regulatory approvals, and the increasing emphasis on large bore vascular closure devices among market players. Also, by shifting some manufacturing process steps to countries like China, India, and Brazil, the manufacturing costs can be brought down, thus mitigating issues related to high costs.

Lack of awareness of physicians regarding the disadvantages of using VCDs at the wrong time, the rising cost of implantable VCDs inhibits the market's growth rate. Vascular closure devices are much more high priced compared to their manual compression counterparts. The average price of a vascular closure device is at least ten times more expensive than a manual compression device in Europe. Moreover, radial artery access makes it more convenient for doctors to achieve homeostasis using simple manual compression methods, thus requiring lesser vascular closure devices, which is another challenging factor. 

Furthermore, malfunctioning products, poor quality, and system inefficiencies contribute to product recalls, costing companies millions of dollars in the product replacement and loss of profits. It also creates a negative impression of the devices, which in turn limits their adoption. Lack of awareness of physicians regarding the disadvantages of using VCDs at the wrong time, the rising cost of implantable VCDs inhibits the growth rate of the market.

This research report on the Europe Vascular Closure Devices Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Passive Approximators
  • Active Approximators
  • External Haemostatic Devices

By Access: 

  • Femoral
  • Radial Access

By Procedure: 

  • Interventional Cardiology
  • Radiology/Vascular Surgery

By End User: 

  • Acute Care Facilities
  • Hospitals
  • Clinics

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European VCDs market was the second leading region in the global vascular closure devices market in 2019. An increase in the per capita income of people and disposable incomes with increasing cardiovascular diseases is responsible for the growth of Europe's market. The high prevalence of cardiovascular disease and the increasing popularity of femoral artery cardiac catheterization are the critical factors driving the growth of the market.

In 2020, The UK vascular closed device market held the most significant market share in the European region due to the increasing prevalence of lifestyle diseases. Government authorities take initiatives to establish innovative technologies and demand sophisticated medical services. Besides, the growing incidence of obesity and the rising prevalence of cardiovascular disease are likely to drive the market in the U.K., heart and circulatory disease causes more than a quarter of 27% of all death, which is about 170000 death annually.

The France vascular closed device market showing the fastest growth rate due to the increasing trend of one-day surgery for vascular procedures and the expanding number of research and clinical trials for vascular closure devices. The European Parliament has announced the deferral of implementing the new Medical Device Regulation by this year. The European vascular closer device market is challenged with urgent needs due to the COVID-19 pandemic, which is relatively hazardous in European nations. As such, the new EU-MDR's deferral will help Medtech companies steady their operations over the next few months and prevent scarcity of medical devices.


A few of the promising companies operating in the European Vascular Closure Devices Market profiled in this report are Biotronik GMBH & CO.KG, Abbott Vascular, Cardinal Health, Merit Medical Systems, Inc., Medtronic, Cardival Medical, Inc., Boston Scientific Corporation, Essential Medical, Inc., W L. Gore & Associates; St. Jude Medical, TZ Medical, Inc., and Scion BioMedical.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample